MX343948B - Compuestos de peroxido organico para inactivacion de microorganismos. - Google Patents

Compuestos de peroxido organico para inactivacion de microorganismos.

Info

Publication number
MX343948B
MX343948B MX2012012335A MX2012012335A MX343948B MX 343948 B MX343948 B MX 343948B MX 2012012335 A MX2012012335 A MX 2012012335A MX 2012012335 A MX2012012335 A MX 2012012335A MX 343948 B MX343948 B MX 343948B
Authority
MX
Mexico
Prior art keywords
organic peroxide
peroxide compounds
microorganism inactivation
inactivation
microorganism
Prior art date
Application number
MX2012012335A
Other languages
English (en)
Other versions
MX2012012335A (es
Inventor
Peter Gregersen Jens
Grundemann Thomas
Original Assignee
Novartis Ag *
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag * filed Critical Novartis Ag *
Publication of MX2012012335A publication Critical patent/MX2012012335A/es
Publication of MX343948B publication Critical patent/MX343948B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N31/00Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
    • A01N31/02Acyclic compounds
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/02Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms
    • A01N43/24Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with one or more oxygen or sulfur atoms as the only ring hetero atoms with two or more hetero atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011Details
    • C12N2720/12011Reoviridae
    • C12N2720/12061Methods of inactivation or attenuation
    • C12N2720/12063Methods of inactivation or attenuation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16061Methods of inactivation or attenuation
    • C12N2760/16063Methods of inactivation or attenuation by chemical treatment
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/16011Orthomyxoviridae
    • C12N2760/16111Influenzavirus A, i.e. influenza A virus
    • C12N2760/16161Methods of inactivation or attenuation
    • C12N2760/16163Methods of inactivation or attenuation by chemical treatment

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Agronomy & Crop Science (AREA)
  • Environmental Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pest Control & Pesticides (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polymerization Catalysts (AREA)

Abstract

La presente invención se refiere a peróxidos orgánicos multifuncionales como inactivadores microbiológicos y/o para degradar ácidos nucleicos. Éstos incluyen por lo menos un átomo de carbono y por lo menos dos grupos peróxido orgánicos. El inactivador es idealmente un hidroperóxido. La invención es particularmente útil durante la preparación de vacunas virales.
MX2012012335A 2010-05-06 2011-05-06 Compuestos de peroxido organico para inactivacion de microorganismos. MX343948B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US39511710P 2010-05-06 2010-05-06
PCT/IB2011/001394 WO2011138682A2 (en) 2010-05-06 2011-05-06 Organic peroxide compounds for microorganism inactivation

Publications (2)

Publication Number Publication Date
MX2012012335A MX2012012335A (es) 2012-11-21
MX343948B true MX343948B (es) 2016-11-30

Family

ID=44532956

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2012012335A MX343948B (es) 2010-05-06 2011-05-06 Compuestos de peroxido organico para inactivacion de microorganismos.

Country Status (11)

Country Link
US (1) US9426989B2 (es)
EP (1) EP2566323A2 (es)
JP (1) JP6072677B2 (es)
KR (1) KR20130079398A (es)
CN (1) CN102946727B (es)
AU (1) AU2011249487C1 (es)
BR (1) BR112012028146A2 (es)
CA (1) CA2796213A1 (es)
EA (1) EA201291179A1 (es)
MX (1) MX343948B (es)
WO (1) WO2011138682A2 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8906963B2 (en) 2011-07-14 2014-12-09 Ecolab Usa Inc Deodorization of peracids
US8883848B2 (en) 2011-07-14 2014-11-11 Ecolab Usa Inc. Enhanced microbial peracid compositions and methods of use at reduced temperatures in aseptic cleaning
GB2495341B (en) 2011-11-11 2013-09-18 Novartis Ag Fermentation methods and their products
ITUA20162517A1 (it) * 2016-04-12 2017-10-12 Andrea Fantozzi Composizione per la conservazione/fissazione di materiale biologico
CN110804641A (zh) * 2019-09-04 2020-02-18 中国农业科学院兰州兽医研究所 一种比较分析不同牛支原体菌株毒力的方法
BR112022008711A2 (pt) 2019-11-07 2022-07-19 Seqirus Uk Ltd Métodos para produzir uma vacina viral e reduzir o tamanho da partícula viral

Family Cites Families (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127618C (es) * 1963-01-16
US3560395A (en) * 1968-09-12 1971-02-02 Pennwalt Corp Aqueous ketone peroxide-hydrogen peroxide composition
US4060644A (en) * 1976-02-09 1977-11-29 Interox Chemicals Limited Bleaching
DE2933498A1 (de) 1979-08-18 1981-04-09 Dr.rer.nat. Hans-Dieter 4234 Alpen Deppe Chemothermisches desinfektions- und sterilisationsverfahren
PH25669A (en) * 1985-12-19 1991-09-04 Padmini Sampathkumar Anaerobe-selective antibacterial compositions, methods
EP0461700A1 (en) 1990-06-12 1991-12-18 Akzo Nobel N.V. Aqueous disinfectant compositions, and concentrates for preparing the same
US5437868A (en) 1991-07-23 1995-08-01 Ecolab Inc. Peroxyacid antimicrobial composition
GB9222561D0 (en) * 1992-10-27 1992-12-09 Ici Plc Macromolecular degradation
US5824536A (en) * 1994-08-23 1998-10-20 St. Jude Children's Research Hospital Influenza virus replicated in mammalian cell culture and vaccine production
FR2738127B1 (fr) 1995-08-30 1998-03-27 Oreal Applicateur de mascara
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
GB9612035D0 (en) * 1996-06-08 1996-08-07 Oilfield Chemical Additives Li Method of inhibiting reservoir souring by bacteria
DE19817743A1 (de) * 1998-04-21 1999-10-28 Binker Materialschutz Gmbh Materialschutzmittel
AU758625B2 (en) * 1998-08-20 2003-03-27 Ecolab Inc. The treatment of meat products
PL355287A1 (en) 1999-09-24 2004-04-05 Smithkline Beecham Biologicals S.A. Intranasal influenza virus vaccine
DE60142506D1 (de) 2000-03-03 2010-08-19 Chemo Sero Therapeut Res Inst In serumfreier kultur verwendbare zelle, kultursuspension und verfahren zur virusproduktion als impfstoff unter verwendung der zelle
FR2808803B1 (fr) 2000-05-11 2004-12-10 Agronomique Inst Nat Rech Cellules es modifiees et gene specifique de cellules es
GB0024089D0 (en) 2000-10-02 2000-11-15 Smithkline Beecham Biolog Novel compounds
US20020107288A1 (en) * 2000-12-08 2002-08-08 Singh Waheguru Pal Methods of sterilizing with dipercarboxylic acids
US7316824B2 (en) 2000-12-15 2008-01-08 Ecolab Inc. Method and composition for washing poultry during processing
EP1361889A1 (en) 2001-02-23 2003-11-19 GlaxoSmithKline Biologicals S.A. Novel vaccine
PT1361890E (pt) 2001-02-23 2011-06-07 Glaxosmithkline Biolog Sa Formulações vacinais de influenza para distribuição intradérmica
MY134424A (en) 2001-05-30 2007-12-31 Saechsisches Serumwerk Stable influenza virus preparations with low or no amount of thiomersal
US20030012804A1 (en) * 2001-06-22 2003-01-16 Aquacide And Use Aquacide and use
JPWO2003014338A1 (ja) * 2001-08-02 2004-11-25 アンジェスMg株式会社 不活性化ウイルスエンベロープの製造方法
DE10144903A1 (de) 2001-09-12 2003-03-27 Chiron Behring Gmbh & Co Vermehrung von Viren in Zellkultur
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
FR2832423B1 (fr) 2001-11-22 2004-10-08 Vivalis Systeme d'expression de proteines exogenes dans un systeme aviaire
CN1194984C (zh) * 2002-02-04 2005-03-30 中国农业科学院植物保护研究所 一种抗生素及其制备方法和应用
FR2836924B1 (fr) 2002-03-08 2005-01-14 Vivalis Lignees de cellules aviaires utiles pour la production de substances d'interet
JP4299514B2 (ja) * 2002-08-29 2009-07-22 長谷川香料株式会社 抗菌抗カビ剤
DE10306018A1 (de) * 2003-02-13 2004-09-09 Siemens Ag Analyse- und Diagnostikinstrument
JP2006523657A (ja) * 2003-04-16 2006-10-19 ネオケミカル デザロージョス アバンサードス,ソシエダ アノニマ 殺生物剤:殺菌剤、防腐剤、消毒剤及び駆虫剤としてのジアルキルケトンペルオキシドの使用
EP1528101A1 (en) 2003-11-03 2005-05-04 ProBioGen AG Immortalized avian cell lines for virus production
WO2005113756A1 (en) 2004-05-14 2005-12-01 Glaxosmithkline Biologicals S.A. Method
CN101094915A (zh) 2004-05-20 2007-12-26 益得生物医学公司 生产流感疫苗的方法
EP1831353B1 (en) 2004-12-23 2012-02-29 MedImmune, LLC Non-tumorigenic mdck cell line for propagating viruses
GB0505909D0 (en) 2005-03-23 2005-04-27 Univ Leeds Formulations
FR2884255B1 (fr) 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
WO2008039171A2 (en) * 2005-08-08 2008-04-03 Oregon Health & Science University Inactivating pathogens with hydrogen peroxide for vaccine production
WO2007042175A1 (en) * 2005-10-07 2007-04-19 Dsm Ip Assets B.V. Peroxide decomposition catalyst
NZ567817A (en) 2005-11-01 2012-01-12 Novartis Vaccines & Diagnostic Cell-derived viral vaccines with low levels of residual cell DNA by beta-propiolactone treatment
ES2286949B1 (es) * 2006-05-26 2008-11-01 Braulio Peña Rodriguez Uso de combinaciones de peroxido de metil etil cetona por pulverizacion.
NZ577405A (en) 2006-12-06 2012-08-31 Novartis Ag Vaccines including antigen from four strains of influenza virus

Also Published As

Publication number Publication date
AU2011249487A1 (en) 2012-09-27
CN102946727B (zh) 2015-08-19
CN102946727A (zh) 2013-02-27
EA201291179A1 (ru) 2013-04-30
KR20130079398A (ko) 2013-07-10
AU2011249487B2 (en) 2014-10-02
EP2566323A2 (en) 2013-03-13
US9426989B2 (en) 2016-08-30
WO2011138682A3 (en) 2012-03-15
AU2011249487C1 (en) 2015-05-14
BR112012028146A2 (pt) 2015-09-15
WO2011138682A8 (en) 2012-07-19
WO2011138682A2 (en) 2011-11-10
JP6072677B2 (ja) 2017-02-01
CA2796213A1 (en) 2011-11-10
JP2013528586A (ja) 2013-07-11
US20130149194A1 (en) 2013-06-13
MX2012012335A (es) 2012-11-21

Similar Documents

Publication Publication Date Title
MX343948B (es) Compuestos de peroxido organico para inactivacion de microorganismos.
PH12015501017A1 (en) Alternative uses for hbv assembly effectors
PH12015501953A1 (en) Substituted nucleotide analogs
EP3426789A4 (en) MICRO-ORGANISMS AND METHOD FOR THE PRODUCTION OF ETHYLENE GLYCOL AND THREE CARBON COMPOUNDS TOGETHER
MX2012008738A (es) Microorganismos y metodos para la biosintesis de p-toluato y tereftalato.
EA030115B9 (ru) Новые 6-конденсированные гетероарилдигидропиримидины для лечения и профилактики заражения вирусом гепатита b
WO2011110343A8 (en) Appliance, particularly kitchen appliance or laboratory table and deodorant device
EP2588121A4 (en) C5A ANALOGUES AND METHODS OF USE THEREOF
MX2017008561A (es) Novedoso bacteriófago clo-pep-1 de clostridium perfringens y su uso para inhibir la proliferación de clostridium perfringens.
WO2013181647A3 (en) Compositions and methods of producing isoprene and/or industrrial bio-products using anaerobic microorganisms
SG179566A1 (en) Hcv protease inhibitors
WO2009002772A3 (en) Bioreactor
MX2013000656A (es) Metodos para la preparacion de profarmacos de fosforamidato diastereomericamente puros.
CA2798214C (en) Vaccine against beta-herpesvirus infection and use thereof
EP2563926A4 (en) MICROORGANISMS AND METHODS OF PROPYLENE BIOSYNTHESIS
PH12015501637A1 (en) Inactivated dengue virus vaccine with aluminium-free adjuvant
MX352082B (es) Inactivacion viral utilizando un metodo mejorado de solvente-detergente.
WO2015177800A3 (en) Recombinant microorganisms capable of carbon fixation
WO2013009910A3 (en) Eosinophil peroxidase compositions and methods of their use
MX2013006170A (es) Formulaciones virales liquidas.
IN2014MN00246A (es)
WO2011029536A3 (de) Verwendung von cyclischen ketoenolen gegen pflanzenpathogene bakterien
BR112017000846A2 (pt) bactérias termofílicas geneticamente modificadas que produzem ácido (r)-láctico
MX2013007055A (es) Derivados de sanglifehrina y metodos para su produccion.
GB201008123D0 (en) Novel compounds

Legal Events

Date Code Title Description
FG Grant or registration